Bronstein, Gewirtz & Grossman, LLC Is Investigating Zynex, Inc. (ZYXI) And Encourages Stockholders to Connect
Portfolio Pulse from
Zynex, Inc. (ZYXI) is under investigation by Bronstein, Gewirtz & Grossman, LLC following a 51.3% stock price decline after reporting Q4 2024 financial results. The company disclosed revenue shortfalls and a temporary payment suspension by Tricare, which represents 20-25% of its annual revenue.
March 21, 2025 | 2:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Legal firm investigating potential claims related to revenue reporting and stock price decline. Tricare payment suspension and revenue shortfall are key concerns.
The investigation, significant stock price drop, and Tricare payment suspension suggest potential financial reporting issues that could negatively impact investor confidence.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100